Procter & Gamble Health Reports Strong FY26 Performance and Substantial Dividend

Procter & Gamble Health has announced its audited financial results for the fiscal year ending March 31, 2026. The company reported revenue from operations at ₹1,407.97 crore and a net profit of ₹326.91 crore.

Key Financial Highlights

The company posted ₹1,407.97 crore in revenue and ₹326.91 crore in net profit for the fiscal year. For the fourth quarter ending March 31, 2026, revenue was ₹370.45 crore, with a net profit of ₹94.60 crore. The board has recommended a final dividend of ₹45 per equity share.

Shareholder Returns

With the recommended final dividend of ₹45 per share, combined with an earlier interim and one-time special dividend of ₹160 per share, the total dividend payout for FY26 reaches ₹205 per equity share. This substantial return to shareholders is subject to approval at the Annual General Meeting.

Auditor's Opinion

Procter & Gamble Health received an unmodified opinion from its statutory auditors on the financial results, indicating that the statements present a true and fair view of the company's financial position.

Reporting Calendar Shift

It's important to note that Procter & Gamble Health transitioned its financial year-end from June 30th to March 31st. The preceding fiscal year, 2024-25, covered a nine-month period. This change means direct year-on-year comparisons of annual figures may be challenging due to the differing reporting durations.

Operational Notes

The company operates in a single reportable segment, Pharmaceuticals. Management has assessed the impact of new Labour Codes and determined it is not material to current salary structures.

Investor Watch

Investors should be aware of the statistical difficulty in directly comparing the current 12-month financial performance with the prior 9-month period when assessing growth trends.

Future Focus

Looking ahead, investors will monitor the company's performance in the upcoming financial year as it navigates its first full year under the new reporting calendar, with a focus on stabilized growth and operational efficiency. The company expects to pay the final dividend on or before September 25, 2026.